Welcome to our dedicated page for MARINEMAX SEC filings (Ticker: HZO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MARINEMAX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MARINEMAX's regulatory disclosures and financial reporting.
MarineMax, Inc. announced that its Board of Directors has approved a new stock repurchase plan authorizing the company to buy back up to $100 million of its common stock from now through March 2028. This new authorization replaces a March 2024 plan that also allowed up to $100 million of repurchases through March 2026, under which approximately 1.4 million shares had been repurchased as of March 3, 2026. The company may repurchase shares in open-market trades or privately negotiated block transactions, primarily to offset dilution from restricted stock and for general corporate purposes. As of March 3, 2026, MarineMax had 22,027,414 shares of common stock outstanding.
MarineMax, Inc. held its Annual Meeting on March 3, 2026, where shareholders approved all four proposals on the ballot. They re-elected three directors—William Brett McGill, Odilon Almeida, and Daniel Schiappa—for three-year terms expiring in 2029.
Shareholders approved, on an advisory basis, the Company’s executive compensation, and also approved an amendment to the 2021 Stock-Based Compensation Plan to increase the number of shares available for issuance under the plan by 415,000 shares. In addition, shareholders ratified the appointment of KPMG LLP as independent auditor for the fiscal year ending September 30, 2026.
MarineMax, Inc. has filed a shelf registration statement allowing it to offer up to $300,000,000 of securities over time. The company may issue common stock, preferred stock, debt securities, depositary shares, warrants, purchase contracts, or units in one or more offerings with terms set in future prospectus supplements.
MarineMax’s common stock trades on the NYSE under the symbol HZO, with 22,027,414 shares outstanding as of January 29, 2026. The company operates over 120 locations worldwide, including more than 70 retail dealerships and over 65 marina and storage locations, and uses proceeds for general corporate purposes such as debt repayment, working capital, capital expenditures, acquisitions, and share repurchases.
MarineMax, Inc. reported a challenging quarter for the three months ended December 31, 2025. Revenue rose 7.8% to $505.2 million, driven by a 10.7% increase in comparable-store sales and contributions from higher-margin marina, service, and ancillary businesses.
Despite top-line growth, gross profit fell to $160.5 million, and gross margin contracted to 31.8% from 36.2% as a more promotional retail environment and mix shift pressured boat margins. Selling, general, and administrative expenses increased 19.1% to $155.6 million, partly reflecting the absence of prior-year fair value reductions on contingent consideration.
Income from operations dropped sharply to $4.9 million from $39.0 million. The company posted a net loss attributable to MarineMax of $7.9 million, compared with net income of $18.1 million a year earlier, translating to diluted earnings per share of $(0.36) versus $0.77.
Operating cash flow improved significantly to an inflow of $16.9 million, largely helped by lower inventories and working capital improvements, compared with a $146.1 million outflow in the prior-year period. Inventories remained high at $867.9 million, while short-term floor plan borrowings were $702.7 million and long-term debt totaled $384.3 million. The company stated it was in compliance with all covenants under its $950 million asset-based credit facility and related term and mortgage loans.
MarineMax, Inc. furnished an update on its business by reporting financial results for its first fiscal quarter ended December 31, 2025. The company did this through a press release dated January 29, 2026, which is attached as Exhibit 99.1.
The report is provided under a rule that treats the information as “furnished” rather than “filed,” meaning it is not subject to certain liability provisions and is not automatically included in other securities filings. The 8-K mainly serves to formally transmit the earnings press release to investors and regulators.
MarineMax, Inc. is asking shareholders to vote at its March 3, 2026 annual meeting on key corporate matters. Shareholders will elect three Class I directors to terms ending in 2029, cast an advisory vote on executive compensation, consider an amendment to the 2021 Stock-Based Compensation Plan to increase shares available under the plan by 415,000, and ratify KPMG LLP as auditor for the fiscal year ending September 30, 2026.
The proxy statement details the company’s classified, majority-vote board structure, committee memberships, and an independent chair model. It explains a pay-for-performance compensation philosophy in which most named executive officer pay is variable, tied to pretax income, inventory aging, and net promoter scores, and delivered largely through restricted stock units. It also outlines enhanced 2026 incentive design, director qualifications, risk oversight, and social and environmental policies.
Dimensional Fund Advisors LP has filed an amended Schedule 13G reporting beneficial ownership of 1,044,643 shares of MarineMax Inc common stock, representing 4.8% of the class as of 12/31/2025. Dimensional reports sole power to vote 1,014,478 shares and sole power to dispose of 1,044,643 shares.
The shares are held across various investment funds and accounts advised or managed by Dimensional and its subsidiaries, and Dimensional states that all securities are owned by these funds. Dimensional disclaims beneficial ownership of the securities beyond what is required for Section 13(d) reporting and certifies that the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of MarineMax.
MarineMax, Inc. reported that Adam M. Johnson resigned from its Board of Directors effective January 16, 2026. The company stated that his decision was not due to any disagreement with MarineMax regarding its operations, policies, or practices, indicating an orderly departure rather than a conflict-driven exit. Following this resignation, the Board will consist of seven directors, so overall board size remains robust for governance and oversight.
MarineMax, Inc. received an updated ownership report on its common stock from several American Century entities and the Stowers Institute for Medical Research. American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute each report beneficial ownership of 2,165,158 shares of MarineMax common stock, representing 9.9% of the class. American Century Capital Portfolios, Inc. separately reports beneficial ownership of 1,324,505 shares, or 6.1% of the class.
The filing states that these securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of MarineMax. Various clients of American Century Investment Management have the right to receive dividends or sale proceeds, but no individual client holds more than 5% of the class.